Lorcaserin
Back to searchMolecule Structure
Scientific Name
Lorcaserin
Description of the Drug
Lorcaserin is a serotonin 2C receptor agonist used in conjunction with physical activity and calorie restriction for weight loss in obese patients with a body mass index (BMI) of 30 and above, and in overweight patients with weight-related comorbidities.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04871
http://www.drugbank.ca/drugs/DB04871
Brand Name(s)
Not Available
Company Owner(s)
Eisai Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | AGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL169382 | ||
DrugBank | DB04871 | ||
PubChem: Thomson Pharma | 16769280 | ||
PubChem | 11658860 | ||
LINCS | LSM-45745 | ||
Nikkaji | J3.095.767I | ||
PDBe | T4U | ||
BindingDB | 50161646 | ||
EPA CompTox Dashboard | DTXSID3048659 | ||
DrugCentral | 4374 | ||
Brenda | 219688 | ||
ChemicalBook | CB61011744 | ||
Guide to Pharmacology | 2941 | ||
rxnorm | LORCASERIN HYDROCHLORIDE | BELVIQ | LORCASERIN |
PubChem: Drugs of the Future | 81044375 | ||
ChEBI | 65353 | ||
ZINC | ZINC000006733300 |